3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Iodine-131
11
Thyrotropin Alfa
9
Sorafenib
8
lenvatinib
6
Thyroidectomy
6
vandetanib
5
Sunitinib
5
Saline Solution
5
pazopanib
4
Triiodothyronine
4
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Vemurafenib
3
Thyroxine
3
Radiotherapy
3
Everolimus
3
Dexmedetomidine
3
Control Groups
3
Cisplatin
3
AZD 6244
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
trametinib
2
tipifarnib
2
romidepsin
2
dabrafenib
2
belinostat
2
Trastuzumab
2
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thyroid Neoplasms
×
Molecular Diagnostic Techniques
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled